Background-Aging negatively impacts on the function of resident human cardiac progenitor cells (hCPCs). Effective regeneration of the injured heart requires mobilization of hCPCs to the sites of damage. In the young heart, signaling by the guidance receptor EphA2 in response to the ephrin A1 ligand promotes hCPC motility and improves cardiac recovery after infarction. Methods and Results-We report that old hCPCs are characterized by cell-autonomous inhibition of their migratory ability ex vivo and impaired translocation in vivo in the damaged heart. EphA2 expression was not decreased in old hCPCs; however, the elevated level of reactive oxygen species in aged cells induced post-translational modifications of the EphA2 protein. EphA2 oxidation interfered with ephrin A1-stimulated receptor auto-phosphorylation, activation of Src family kinases, and caveolin-1-mediated internalization of the receptor. Cellular aging altered the EphA2 endocytic route, affecting the maturation of EphA2-containing endosomes and causing premature signal termination. Overexpression of functionally intact EphA2 in old hCPCs corrected the defects in endocytosis and downstream signaling, enhancing cell motility. Based on the ability of phenotypically young hCPCs to respond efficiently to ephrin A1, we developed a novel methodology for the prospective isolation of live hCPCs with preserved migratory capacity and growth reserve. Conclusions-Our data demonstrate that the ephrin A1/EphA2 pathway may serve as a target to facilitate trafficking of hCPCs in the senescent myocardium. Importantly, EphA2 receptor function can be implemented for the selection of hCPCs with high therapeutic potential, a clinically relevant strategy that does not require genetic manipulation of stem cells. neighboring cells expressing the Eph receptors. 11,12 EphA2 is preferentially expressed in immature hCPCs, whereas the corresponding ligand, ephrin A1, is distributed on the plasma membrane of myocytes, 10 which act as supporting cells within the stem cell niches.
A ctivation, growth, and commitment of resident c-kitpositive cardiac progenitor cells (CPCs) maintain the homeostasis of the adult myocardium by restoring dying cells with newly formed cardiomyocytes and vascular cells. 1, 2 The efficacy of these processes declines progressively, and the impairment in the mechanisms of clearance and replacement of old myocytes dictates the manifestations of the aging myopathy. [3] [4] [5] Although the number of CPCs increases in the old myocardium, 5 the regenerative response of the senescent heart is inadequate raising the possibility that chronological age negatively impacts on CPC function.
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Defects in the replication and migration of CPCs are critical determinants of organ homeostasis and repair, and these properties are defective in the senescent heart in rodents. 3, 4 Old, poorly contracting myocytes accumulate and cardiac performance deteriorates, mimicking the aging myopathy in humans. 6 The attenuated function of human CPCs (hCPCs) in the old myocardium may be mediated by age-dependent alterations in their motile state. Although experimental observations support this hypothesis, 4 whether the mobilization of hCPCs is affected by age is currently unknown. Defective migration of hCPCs may oppose their egress from the niches and translocation within the myocardium, where regeneration of myocytes and coronary vessels is required for the preservation of the structural integrity of the organ.
A guidance system that controls the migration of stem cells involves the family of Eph receptor tyrosine kinases and ephrin ligands. [7] [8] [9] [10] Ephrins are membrane-bound proteins that participate in a complex contact-dependent communication with November 12, 2013 neighboring cells expressing the Eph receptors. 11, 12 EphA2 is preferentially expressed in immature hCPCs, whereas the corresponding ligand, ephrin A1, is distributed on the plasma membrane of myocytes, 10 which act as supporting cells within the stem cell niches. 13 EphA2 downregulation abrogates the binding of hCPCs to ephrin A1 and interferes with ephrin A1-induced motility, documenting that EphA2 operates as a primary receptor for ephrin A1 ligand in this progenitor cell class. 10 Importantly, EphA2 blockade inhibits the motile response of young hCPCs to hepatocyte growth factor (HGF), 10 a powerful chemoattractant implicated in CPC mobilization. 4, 14, 15 Thus, EphA2 plays a key role in hCPC trafficking and alterations in ephrin A1/ EphA2 signaling may cause defects in the migration of old hCPCs. In the present study, we tested whether decreased function of the EphA2 receptor conditions the loss of movement in senescent hCPCs, offering a molecular target for the restoration of the motile state in aging cells.
Methods
A detailed description of the methods used in this study is provided in the online-only Data Supplement.
Human CPCs
hCPCs were isolated from discarded myocardial tissue of subjects 35-78 years of age and were cultured ex vivo as previously described (IRB protocol 2010P002475). 10, 16 To induce replicative senescence, hCPCs were expanded for 4-7 passages (P) and further propagated till P11-P15. Stress-induced senescence was achieved by 18-hr exposure of hCPCs at P4-P7 to 0.5 µmol/L doxorubicin (Sigma; Figure I in the online-only Data Supplement).
Immunofluorescence and Confocal Microscopy Analysis
Indirect immunolabeling of hCPCs was performed after fixation and permeabilization. 4, 10, [16] [17] [18] The list of primary antibodies and secondary reagents, as well as the details of the protocol, are provided in the Methods of the online-only Data Supplement.
Immunoprecipitation, Immunoblotting, and 2-Dimensional Gel Analysis
For these assays, protein extracts were obtained from whole myocardium and total cell lysates of young and old hCPCs.
Flow-Cytometry Studies
The expression of EphA2 and c-Met on the plasma membrane of hCPCs was determined by flow-cytometry. Telomere length in hCPCs was measured by flow-cytometry and fluorescence in situ hybridization (Flow-FISH), following a previously published protocol. 19, 20 
Transwell Migration
Spontaneous motility and chemotaxis of young and old hCPCs were examined as previously described. 10 
Lentiviral Infection of hCPCs
The pLentiV plasmid for enhanced green fluorescence protein (EGFP) expression and the 3-plasmid system to generate lentiviral particles were used previously. 21 Full-length human EphA2 sequence was cloned into the pLentiV plasmid to enable expression of the EphA2-EGFP fusion protein. The plasmid for lentiviral expression of red fluorescence protein (RFP) was purchased from Thermo Scientific. Infection of hCPCs was carried out as described. 10 ,16,21
Imaging of hCPC Translocation In Vivo
Young and old hCPCs were infected with lentiviruses expressing EGFP or RFP, respectively. The 2 cell populations were combined in a 1:1 ratio, pretreated with ephrin A1, and injected into the myocardium of acutely infarcted mice. 10 The procedures were performed in accordance with institutional guidelines. The protocols for cell transplantation, 2-photon imaging, and quantitative analysis of cell movement are provided in the Methods of the online-only Data Supplement.
Endocytosis of Ephrin A1 and Transferrin
Young and old hCPCs were incubated with fluorescently-labeled transferrin and ephrin A1. To remove ligands bound to the cell surface, hCPCs were subjected to acid wash, and the amount of internalized ligand was calculated as % fluorescence intensity as compared with total ligand content in the cells subjected to washing in neutral pH. Endocytosis dynamics of transferrin and ephrin A1 was studied by live imaging in young and old hCPCs.
Live Imaging of hCPC Migration In Vitro
EGFP-expressing or EphA2-EGFP-infected old hCPCs were subjected to polarized stimulation with HGF and imaged (see Methods of the online-only Data Supplement).
Cell Sorting by Adhesion to Ephrin A1
Adhesion assay of hCPCs to immobilized ephrin A1 was performed as previously published. 10 The expression of p16 INK4a and γH2A.X was determined by immunolabeling and confocal microscopy in adherent and nonadherent hCPCs.
Statistical Analysis
Significance between 2 groups was determined by 2-tailed unpaired Student t test. For multiple comparisons, the ANOVA test with Bonferroni correction was used. Quantitative data are expressed as mean±SD. The n values used in each statistical determination are listed for convenience in the legend to each figure; these values reflect the number of independent experiments performed in triplicates in each case.
Results

Aging Impairs hCPC Motility
Cellular senescence is implicated in the deterioration of organ function and in the aging of the organism. 22, 23 Cells displaying an old phenotype are identified by the expression of senescence-associated biomarkers. 18, 24 Strategies for the isolation of live senescent cells remain to be developed, requiring the implementation of ex vivo models of cellular aging. Two in vitro protocols were introduced to achieve hCPC senescence ( Figure IA in the in the online-only Data Supplement): replicative senescence as a result of serial passaging, 25 and stress-induced senescence by exposure to the oxidative agent doxorubicin. 17 Senescence of hCPCs was documented with several parameters, which included irreversible withdrawal from the cell cycle, expression of the senescence-associated protein p16 November 12, 2013 of p16
INK4a
-positive hCPCs increased 4-fold ( Figure 1B ). DNAdamage response foci were found in nearly 40% and 60% of serially passaged and doxorubicin-treated hCPCs, respectively ( Figure 1C ). Telomere shortening, from 9 kbp to 5.2 kbp, was apparent only in long-term hCPC cultures ( Figure IB and IC in the online-only Data Supplement). Short-term oxidative stress by doxorubicin is more commonly associated with loss of telomere integrity 27 in the absence of changes in average telomere length ( Figure ID in the online-only Data Supplement). Additionally, senescent hCPCs showed flattening and loss of polarization ( Figure IE in the online-only Data Supplement). Thus, old hCPCs were obtained by these two protocols, enabling the comparison of young and old cells isolated from the same human heart, independently from patient's age, sex, absence or presence of pathology, and cause and duration of the cardiac disease. In all studies, hCPCs obtained at early (young) and late (old) passages were used, together with hCPCs cultured in the absence (young) and presence (old) of doxorubicin.
Experimentally, the migratory capacity of CPCs in the myocardium declines with age, 4 but the mechanisms responsible for this functional alteration are largely unknown. The ephrin A1/EphA2 pathway and HGF/c-Met signaling favor the mobilization of CPCs in the aged or infarcted heart. 4, 10, 14, 15 Additionally, the expression of EphA2 is required for HGFinduced chemotaxis of hCPCs, and activation of EphA2 by ephrin A1 potentiates the migration of this cell class. 10 The spontaneous motility and chemotaxis towards HGF were severely affected in old hCPCs ( Figure 1D ). Importantly, EphA2 stimulation with ephrin A1 promoted cell movement in young but not in old hCPCs ( Figure 1D ). In the presence of HGF, young hCPCs acquired a polarized morphology and redistributed EphA2 to the leading lamella 10 ; this response was not observed in old cells ( Figure 1E ). The defects in the migratory behavior of old hCPCs were comparable in the 2 models of senescence, indicating that aging per se has detrimental effects on hCPC motility.
To determine whether these in vitro findings had a functional counterpart in vivo, young and old hCPCs were infected with a lentiviral vector carrying green or red fluorescent protein. After stimulation with ephrin A1, young and old hCPCs were cotransplanted in the border zone of acutely infarcted hearts and their displacement within the myocardium was measured by 2-photon microscopy over a period of 6 hours. Ephrin A1-activated young hCPCs showed an average 2.4-fold higher translocation velocity than ephrin A1-treated old hCPCs ( Figure 1F and 1G) . Additionally, the percent of nonmigrating old hCPCs was 2.9-fold larger than that of young hCPCs ( Figure 1G and Movie I in the online-only Data Supplement). Thus, activation of the ephrin A1/EphA2 signaling enhances the trafficking of young hCPCs in vitro and in vivo, but does not reverse the defect in the motile state of old hCPCs.
Ephrin A1-Induced EphA2 Endocytosis Is Altered in Old hCPCs
The impairment in the motility of old hCPCs within the myocardium may reflect alterations in the expression of ephrin A1 ligand, its corresponding receptor EphA2, or the downstream signaling pathway. With chronological age, the level of ephrin A1 decreased slightly in the human heart ( Figure 1H ), in which ephrin A1 is confined to the myocyte compartment. 10 The decline in ephrin A1 was more apparent in senescent p16
INK4a
-positive myocytes ( Figure 1I ). However, exposure to saturating levels of ephrin A1 did not correct the defects in the motile properties of old hCPCs (see Figure 1D , 1F and 1G), suggesting that EphA2 function is a crucial determinant of hCPC migration.
Because the expression of EphA2 and c-Met proteins did not differ in young and old hCPCs ( Figure II in the online-only Data Supplement), we determined whether dysfunction of the EphA2 receptor was implicated in the migration abnormalities of old hCPCs observed in vitro and in vivo. In our study, we focused on EphA2 because the integrity of this pathway is essential for the chemotactic response of hCPCs to HGF. 10 Ephrin binding to Eph receptors leads to internalization of the ligand/receptor complex from the plasma membrane to the cytosol. 28, 29 By using fluorescently labeled ephrin A1, the amount of ligand internalized by young and old hCPCs was measured quantitatively. In comparison with young hCPCs, EphA2-mediated ephrin A1 endocytosis was markedly decreased in old hCPCs (Figure 2A and 2B) . The subcellular distribution of the ephrin A1/EphA2 complex also differed in the two hCPC classes. The ligand-receptor pair accumulated in the perinuclear region of young hCPCs but was restricted to vesicles near the plasma membrane of old cells ( Figure 2C ). This defect was not observed with the transferrin ligand. The simultaneous analysis of ephrin A1 and transferrin endocytosis in old hCPCs showed that, in contrast to ephrin A1, transferrin was internalized and translocated to the perinuclear endosomes (see Figure 2A and 2B), pointing to the absence of a global defect in the endocytic machinery of old hCPCs.
The motility and sub-cellular distribution of endosomes are strictly related to their stage of maturation. Within minutes of ligand binding, multiple vesicles form at the periphery of the cell and undergo slow nondirectional short-range oscillations, which convert into rapid directional long-range movements. This process results in the translocation of vesicles to the perinuclear region. 30 The dynamics of endosomes containing fluorescently labeled ephrin A1 was studied by live imaging in young and old hCPCs. Ephrin A1 was efficiently transported from the plasma membrane to the perinuclear region in young cells (Movie II in the online-only Data Supplement). Conversely, the displacement of the ephrin A1 cargo lacked directionality in old hCPCs, in which endosomes largely The movement of endocytic vesicles from the plasma membrane to the perinuclear area is coupled with their progressive enlargement. 30 Exposure of young hCPCs to ephrin A1 resulted in a time-dependent increase in the average size of the EphA2-containing vesicles ( Figure 2F and 2G) . In young hCPCs, EphA2-endosomes, >3 µm 2 , were found in the perinuclear region and smaller EphA2-vesicles, <2 µm 2 , were predominantly located at the periphery of the cells ( Figure 2F ). Five minutes after stimulation with ephrin A1, the size of the EphA2 clusters was comparable in young and old hCPCs ( Figure 2G ). However, the evolution of EphA2-vesicles into larger endosomes was significantly hindered in old hCPCs ( Figure 2F and 2G). These results suggest that defects in the maturation of the primary endocytic vesicles carrying ephrin A1/EphA2 occur in old hCPCs and may have an impact on the fate of the internalized EphA2 receptor and its downstream signaling. 28, 29, 31 Primary endosomes containing the ligand/receptor complex are transported to and fused with early endosomes that function as sorting domain for cargo recycling to the cell surface, or cargo degradation in lysosomes. 30, 31 Early endosomes, which are recognized by the presence of the early endosome antigen 1 (EEA1), fuse with late endosomes/lysosomes expressing the lysosomal-associated membrane protein 1 (LAMP1). 30, 31 The colocalization of internalized ephrin A1/EphA2 with EEA1-endosomes increased in a time-dependent manner in young hCPCs ( Figure 3A-3C ). However, old hCPCs exhibited a significant decrease in the colocalization of ephrin A1/EphA2 with EEA1 and an increase in association with LAMP1-positive vesicles ( Figure 3B and 3D). In old hCPCs, the fusion of ephrin A1/EphA2 with LAMP1-endosomes was apparent at the cell periphery, and seemingly did not involve EEA1 Figure 3B ). Thus, endosomal targeting of the ligandbound EphA2 receptor is altered in old hCPCs; a smaller fraction of internalized EphA2 persists in early endosomes, but a larger proportion of this receptor is destined to the late endosomal compartment, possibly undergoing degradation.
30,31
EphA2 Endocytosis Is Mediated by Caveolin-1 and Src Family Kinases
Clathrin-and caveolin-dependent endocytosis is a major route by which receptors internalize from the plasma membrane to the cytoplasm. Endocytosis of Eph receptors is mediated by both clathrin and caveolin. 32, 33 The EphA2 protein contains a putative caveolin-binding motif that directly interacts with caveolin-1 in response to ligand stimulation. 32 Caveolin-1 and caveolin-2 isoforms were expressed in hCPCs, whereas caveolin-3 was not detectable ( Figure IIIA in the online-only Data Supplement).
The distribution of EphA2 and caveolin-1 in hCPCs was determined biochemically and by immunolabeling and confocal microscopy. In response to ephrin A1, caveolin-1 colocalized with EphA2 in the EEA1-endosomes of young hCPCs ( Figure 4A and Figure IIIB in the online-only Data Supplement).
By immunoprecipitation and Western blot, caveolin-1 was found to form a complex with EphA2 in young hCPCs, and this protein-to-protein interaction increased significantly with ephrin A1 stimulation ( Figure 4B ). The subcellular distribution of caveolin-2 resembled that of caveolin-1; however, internalized EphA2 showed a preferential association with caveolin-1 ( Figure The interaction of EphA2 with caveolin-1 was severely affected in old hCPCs ( Figure 4A and 4B) , suggesting that the recruitment of caveolin-1 to the activated receptor was impaired as a result of a defect in EphA2 signaling. This hypothesis was supported by the decrease in EphA2 receptor tyrosine phosphorylation in old hCPCs after ephrin A1 binding ( Figure 4B) ; Eph autophosphorylation is a hallmark of receptor activation. 11 The degree of EphA2 phosphorylation triggered by ephrin A1 stimulation is determined by the equilibrium between autophosphorylation of receptor tyrosine kinases and dephosphorylation of tyrosine residues by protein tyrosine phosphatases. 28, 34 Dephosphorylation of EphA2 may be accelerated in old hCPCs, attenuating EphA2 signaling. However, inhibition of protein tyrosine phosphatases with pervanadate led to a reduction in ephrin A1-induced EphA2 endocytosis ( Figure  IV in the online-only Data Supplement), arguing against the possibility that an increased protein tyrosine phosphatase activity interferes with EphA2 function in old hCPCs.
In young cells stimulated with ephrin A1, the endosomes carrying EphA2 and caveolin-1 or EEA1 were characterized by accumulation of phospho-tyrosine labeling, which was greatly reduced in old hCPCs exposed to ephrin A1 (Figure V in the online-only Data Supplement). These results suggest that EphA2 receptor tyrosine kinase signaling is maintained in endosomes of young hCPCs, whereas EphA2 autophosphorylation and endocytosis were markedly reduced in old hCPCs, negatively impacting on the EphA2 downstream pathway.
The Src family kinases (SFK) are well-established downstream effectors of the Eph receptors. 11, 12 Consistent with previous observations in hCPCs, 10 EphA2 stimulation with ephrin A1 induced SFK activation and enhanced the binding of EphA2 to SFK ( Figure 4B ). In young hCPCs, ephrin A1 promoted the formation of endocytic vesicles in which EphA2 colocalized with the phosphorylated active forms of SFK and caveolin-1 ( Figure 4C ). Caveolin-1 phosphorylation at Tyr 14 controls the internalization of caveolae and is implicated in the signaling cascade regulating cell motility. 35, 36 Inhibition of SFK, which phosphorylate caveolin-1, prevented the increase in Tyr 14 -caveolin-1 in young hCPCs after ephrin A1 treatment ( Figure 4D ). Additionally, it decreased the accumulation of caveolin-1 in endocytic vesicles ( Figure 4E ), affecting EphA2 endocytosis ( Figure 4F ) and ephrin A1 internalization ( Figure 4G ). Thus, in young hCPCs, activation of SFK is required for caveolin-1-mediated EphA2 endocytosis.
As emphasized above, HGF-induced hCPC migration requires EphA2 activity. 10 Stimulation of hCPCs with HGF led to EphA2 accumulation at the plasma membrane (see Figure 1E) , where ruffles and protrusion indicative of high membrane activity were found. Phosphorylated SFK and caveolin-1 were detected in these regions of membrane activation ( Figure 5A ). The combination of ephrin A1 and HGF had a synergistic or addictive effect on EphA2 endocytosis ( Figure 5B ). Thus, HGF/c-Met signaling affects the cellular distribution of EphA2 receptor, favoring its interaction with downstream targets and promoting cell motility.
Accumulating evidence supports the view that the function of receptor tyrosine kinases is sustained in endosomes, which are operatively defined as signaling endosomes. 30, 37 In young hCPCs, activated EphA2 receptors and their downstream targets, SFK, are present in EEA1-endosomes, possibly reflecting the generation of signaling endosomes. The dynamin inhibitor-dynasore 38 blocks caveolae internalization and ephrin A1-induced EphA2 endocytosis, abrogating hCPC motility ( Figure 6 in the online-only Data Supplement). In old hCPCs, attenuated EphA2 autophosphorylation correlated with the decrease in the formation of protein complexes with SFK or caveolin-1 (see Figure 4B ). EphA2 localization in endosomes containing caveolin-1 or EEA1 was also reduced (see Figure 4A and 4C, and Figure IIIB 
Protein Oxidation Inhibits EphA2 Function in Old hCPCs
Aging is associated with a progressive intracellular accumulation of reactive oxygen/nitrogen species (ROS). 39, 40 Two fluorescent indicators of ROS were used to detect oxidative stress by confocal microscopy and to measure ROS level fluorometrically in hCPCs. By both approaches, old hCPCs were characterized by a significantly higher oxidative stress than young hCPCs ( Figure 6A and 6B) . Controlled production of ROS is critical for signal transduction, whereas an excessive generation of ROS impairs receptor tyrosine kinase activity. 41 Exposure of young hCPCs to acute oxidative stress with H 2 O 2 markedly reduced the ephrin A1-induced EphA2 phosphorylation ( Figure 6C ), mimicking the defects observed in old hCPCs (see Figure 4B) . SFK activation and EphA2 endocytosis were notably diminished in H 2 O 2 -treated young hCPCs ( Figure 6D and 6E) , impairing their migratory ability ( Figure 6F ). Importantly, a shift in the isoelectric point (pI) of the EphA2 protein was detected in old hCPCs and similar changes were found in young hCPCs in the presence of H 2 O 2 ( Figure 6G ). Thus, ROS may induce oxidation of the EphA2 receptor in old hCPCs, precluding its activation and downstream signaling.
These findings prompted us to determine whether treatment of old hCPCs with antioxidants positively affected EphA2 signaling. Old hCPCs, exposed for 1 day to N-acetyl-L-cysteine or polyethylene glycol-catalase, were stimulated with ephrin A1. With N-acetyl-L-cysteine, the association of caveolin-1 with EphA2 was moderately improved, pointing to an amelioration in endocytosis of the ephrin A1/EphA2 complex ( Figure 6H ). Moreover, cell-permeable catalase decreased oxidative stress and favored in a subset of old hCPCs the colocalization of the ligand-receptor pair with EEA1 ( Figure 6I and 6J), mimicking the pathway of EphA2 internalization observed in young cells (see Figure 3A-3C) . The limited effects of antioxidants on EphA2 endocytosis imposed on us the search for alternative strategies aiming at the functional restoration of the receptor. 
Exogenous EphA2 Improves the Motility of Old hCPCs
Old hCPCs were infected with a lentivirus carrying a full-length EphA2-EGFP fusion protein or a lentivirus carrying EGFP only ( Figure 7A and 7B) . Exogenous EphA2, recognized by the EGFP tag, displayed the expected expression pattern on the plasma membrane ( Figure 7C ). With respect to endogenous EphA2, ephrin A1 induced a 5-fold higher level of tyrosine phosphorylation of the exogenous EphA2 receptor (Figure 7D ), which underwent efficient endocytosis and co-localization with caveolin-1 ( Figure 7E and 7F) . Moreover, exogenous EphA2 exhibited greater association with EEA1-endosomes than the endogenous EphA2 protein in the same cell ( Figure 7G ). Conversely, endogenous EphA2 receptors in the same hCPC were primarily colocalized with LAMP1 ( Figure 7H ). The correction of the defects in EphA2 endocytosis improved the motile behavior of old hCPCs exposed to HGF ( Figure 7I and 7J, and Movie III in the online-only Data Supplement). Thus, 
Sorting of Young and Old hCPCs Based on Differential Responses to Ephrin A1
The recognition that defects in the ephrin A1/EphA2 effector pathway alter the molecular mechanisms responsible for hCPC migration provided a unique opportunity to establish whether this system can be used to separate young hCPCs with preserved growth reserve from old non-functional hCPCs. Young hCPCs efficiently adhere to immobilized recombinant ephrin A1 ligand ( Figure 8A and 8B), a process that is abrogated after siRNA-mediated EphA2 knockdown. 10 The defect in EphA2 receptor activity in old hCPCs substantially reduced their ability to adhere to ephrin A1-coated surfaces ( Figure 8B ). hCPCs with a younger phenotype were isolated from the heterogeneous pool of old cells based on their preferential retention on ephrin A1-substrates ( Figure 8A ). In comparison with unsorted and non-adherent old cells, the subset of hCPCs adhering to ephrin A1 displayed a 2-fold lower frequency in the expression of the senescence-associated markers p16 INK4a and γH2A.X ( Figure 8C and 8D) . Thus, EphA2 receptor function can be implemented in the selection of hCPCs with high therapeutic potential.
Discussion
In the present study we provide a potential mechanism for the age-associated decline in the motility of hCPCs. The Figure 7 . Functional EphA2 receptor potentiates ephrin A1 signaling in old hCPCs. A, Old hCPCs were infected with a lentivirus (LV) carrying EphA2-EGFP or EGFP only. Western blotting: EphA2-EGFP fusion protein (eEphA2) has a higher molecular weight (green arrow) than endogenous EphA2 (red arrow). Molecular weight is indicated in kDa. B, Flow-cytometry: EphA2 (red), eEphA2 (green), and EGFP in old hCPCs. Secondary IgG, control (grey). C, In the absence of ephrin A1, exogenous EphA2 (orange: native EGFP fluorescence and immunolabeled red) is highly expressed and is localized on the membrane of old hCPCs. Individual fluorescent signals are illustrated in the lower panels. D, Immunoprecipitation of EphA2 protein (IP: EphA2) and immunoblotting of phospho-tyrosine (IB: pTyr) in LV EphA2-EGFP old hCPCs in the presence (+) or absence (−) of ephrin A1. O.D. data were normalized to the efficiency of eEphA2 and EphA2 immunoprecipitation relative to unstimulated cells (−). Data are mean±SD (n=4). *P=0.035. Exogenous EphA2 (eEphA2, green arrows) has a higher molecular weight than endogenous EphA2 (EphA2, red arrows). E, EphA2 endocytosis after 15-min stimulation with ephrin A1 of LV EGFP and LV EphA2-EGFP old hCPCs. The number of EphA2-containing vesicles is higher in LV EphA2-EGFP hCPCs. F, Exogenous EphA2 (native EGFP fluorescence and immunolabeled red) colocalizes with caveolin-1 (blue) in old LV EphA2-EGFP hCPCs stimulated for 15 min with ephrin A1. This is apparent in area 1 (arrows) shown at higher magnification in the adjacent panel. Endogenous EphA2 (immunolabeled red) failed to colocalize with caveolin-1 (see area 2 at low and high magnification). G and H, In old LV EphA2-EGFP hCPCs, exogenous EphA2 (orange: native EGFP fluorescence and immunolabeled red) colocalizes with EEA1 (G, blue; green arrow in inset 1) but not with LAMP1 (H, blue; green arrows in the insets) after stimulation with ephrin A1 for 15 min. Endogenous EphA2 (immunolabeled red) does not co-localize with EEA1 (G, blue arrow in inset 2) but colocalizes with LAMP1 (H; blue arrows in the insets). Collectively, our data support the view that oxidative stress is an important determinant of cellular and organ aging. 39, 40 The accumulation of ROS in old hCPCs induces post-translational modifications of the EphA2 protein interfering with the receptor tyrosine kinase function. Although the specific residues affected by oxidative stress were not identified, oxidation is known to abrogate receptor activity. 41 The agedependent consequences of EphA2 receptor oxidation were corroborated by comparing the signaling capacity of endogenous and exogenously expressed EphA2 receptors in old hCPCs. In contrast to endogenous EphA2, autophosphorylation of the exogenous EphA2 receptor was profoundly increased after ephrin A1 stimulation. Consequently, endocytosis and the formation of signaling endosomes were corrected by restoring EphA2 function.
The recognition that tyrosine kinase activity is implicated in EphA2 receptor endocytosis is consistent with previous findings. 29, 43 Our work further demonstrates that alterations in the EphA2 endocytic pathway prevent vesicle maturation. The dynamic process of vesicle maturation is characterized by centripetal trafficking of the ephrin A1/EphA2-containing endosomes and vesicle enlargement, both essentially absent in old hCPCs. Moreover, the amount of internalized ephrin A1 ligand in nonmoving vesicles adjacent to the cell surface was decreased in old hCPCs. These defects in the translocation of maturing endosomes carrying EphA2 receptors oppose signalosome assembly, which is required for the rearrangement of the cytoskeleton and acquisition of the motile configuration in old hCPCs.
In the course of endosome maturation, the primary endocytic vesicles containing the internalized cargo fuse with early endosomes at the cell periphery and form larger endosomes as they move towards the nucleus, where the majority of lysosomes are localized. 30 In young hCPCs, fusion of internalized ephrin A1/EphA2 complex with the early endosomes was followed by the association with late endosomes/lysosomes distributed in the perinuclear area. Conversely, in old hCPCs, fusion of EphA2 receptors with early endosomes was significantly reduced, whereas their interaction with LAMP1-expressing vesicles at the cell periphery indicated an alternative pathway or their potential degradation. Thus, cellular aging alters the EphA2 endocytic route, possibly affecting the half-life of the EphA2 receptor and its function.
Results in this study show that activation of EphA2 by ephrin A1 regulates phosphorylation of caveolin-1 and its recruitment to endocytic vesicles. Although the expression of caveolin-1 protein was similar in young and old hCPCs, old cells lacked the polarized caveolin-1 distribution, reflecting an abnormal migratory cell phenotype. 44 Ephrin A1 treatment did not correct this alteration in caveolin-1 localization, indicating that the integrity of the EphA2 pathway constitutes the primary modulator of caveolin-1 function in hCPCs. In this regard, exogenously introduced signaling-competent EphA2 receptors restored the endosomal accumulation of caveolin-1, promoting effective endocytosis. The relevance of EphA2 signaling for the polarization and migration of hCPCs is supported by the findings demonstrating that phosphorylated SFK The spatially-and temporally-restricted compartment of signaling endosomes is implicated in the biological function of receptor tyrosine kinases. 29, 31 Oncogenic Met receptor mutants promote cancer cell migration and are characterized by an enhanced signaling capacity resulting from their preferential accumulation and sustained function in endosomes. 45 Similarly, endocytosis is required for activation of the downstream effectors of the VEGF receptor 46 and vessel sprouting. 47 In contrast, mutation of the EphA8 receptor, which interferes with endocytosis, prevents axon repulsion during development. 48 Our results indicate that formation of signaling endosomes is required to elicit migratory responses in hCPCs, raising the possibility that EphA2 receptor activity in old hCPCs is not sufficient for the signalosome assembly. In old hCPCs, the internalized EphA2 may be targeted to an alternative pathway of receptor recycling/degradation leading to premature signal termination. This hypothesis is supported by the restoration of the motility-related signaling cascade in old hCPCs overexpressing exogenous intact EphA2 receptors. The ectopic receptor is efficiently phosphorylated and subjected to endocytosis, displaying a vesicle maturation pattern typical of young cells, which promotes signaling endosome formation and cell migration.
The loss of migratory ability in old hCPCs affects their translocation within the myocardium, impairing cell turnover in the aging heart. 4 This defect interferes with efficient cardiac repair, having important clinical implications. Extreme caution, however, has to be exercised in the extrapolation of in vitro findings to the in vivo condition. As shown here and previously, 10 after myocardial infarction, ephrin A1 enhances the motility and the regenerative potential of hCPCs expressing intact EphA2 receptor. Although the manifestations of the aging cardiac phenotype are more complex than those found acutely after ischemic injury, the restoration of CPC movement leads to enhanced cardiomyogenesis, decreased fibrosis, and functional improvement in the senescent rat heart. 4 Our data indicate that the expression of functional EphA2 receptors may be implemented for the isolation of hCPCs that possess a young phenotype and higher proliferative capacity. Thus far, no methodology is available for the in vivo separation of human progenitor cells with distinct growth reserve, the most critical determinant of successful cell therapy in patients. This is particularly relevant because autologous hCPCs are currently being tested in phase 1 clinical trials with encouraging results. 20, 49, 50 
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SUPPLEMENTAL MATERIAL Supplemental Methods
Human CPCs
Human c-kit-positive cardiac progenitor cells (hCPCs) were isolated from discarded myocardial tissue and cultured ex vivo as previously described (IRB protocol 2010P002475).
1,2
Specimens were obtained from patients who underwent elective cardiac surgery, or consisted of donor hearts declined for transplantation and explanted hearts. Myocardial samples were enzymatically dissociated and small cardiac cells were sorted for c-kit and cultured. Expanded hCPCs were employed in the in vitro and in vivo studies described in the subsequent sections. To induce replicative senescence, hCPCs were expanded for 4-7 passages (P) and further propagated till P11-15. Stress-induced senescence was achieved by treatment of hCPCs at P4-P7 with 0.5 µM doxorubicin (Sigma) for 18 hr. Cells were then washed and cultured for additional 3-5 days (see Figure S1A) . In all studies, hCPCs obtained at early ("young") and late ("old") passages were employed, together with hCPCs cultured in the absence ("young") and presence ("old") of 
Immunofluorescence and Confocal Microscopy Analysis
For indirect immunolabeling, hCPCs were plated on glass coverslips, fixed for 25 min with 4% paraformaldehyde, permeabilized for 5 min with 0.5% Triton X-100, and incubated with specific antibodies for 45 min at ambient temperature. [1] [2] [3] [4] [5] [6] Primary antibodies included goat anti-human μg/mL goat anti-human EphA2 (R&D), followed by 1 hr incubation with PureProteome protein A magnetic beads (Millipore), according to manufacturer's instruction. EphA2 was detected using rabbit anti-EphA2 (Santa Cruz). Two-dimensional electrophoresis analysis included young hCPCs, old hCPCs, and young hCPCs exposed to acute oxidative stress, 300 μM H 2 O 2 for 30 min. Protein cell lysates was obtained in Tris-HCl buffer with 6M urea, 30% glycerol and 2% SDS; in all cases, 200 μg proteins were separated using ReadyStrip IPG Strips pH3-10 (BioRad) with PROTEAN IEF system (BioRad) and further analyzed by immunoblotting. Optical density of the bands was evaluated using ImageJ.
Flow-Cytometry Studies
The expression of EphA2 on the plasma membrane of hCPCs was determined with goat antihuman EphA2 (R&D), followed by staining with AlexaFluor-647-conjugated anti-goat IgG Blank samples consisted of cells not exposed to the PNA probe. DNA denaturation was performed at 87ºC for 15 min and was followed by 2 hr hybridization at room temperature.
Samples were also labeled with AlexaFluor-488-conjugated rat anti-mouse CD45 (BioLegend) to distinguish mouse lymphocytes and hCPCs. DNA was counterstained with 0.5 µg/mL propidium iodide solution (Sigma). Calibration of the flow-cytometer and calculations of the molecules of equivalent soluble fluorochrome (MESF) units were performed using Quantum APC microspheres (Bang Laboratories). Acquisition was performed with FACPCanto II flowcytometer (BD Biosciences) and data were analyzed using FlowJo v7/9 software (Tree Star).
Transwell Migration
Spontaneous motility and chemotaxis of young and old hCPCs were examined as previously 
Lentiviral Infection of hCPCs
The pLentiV plasmid for the lentiviral expression of EGFP expression, and the 3-plasmid system to generate lentiviral particles (LV-EGFP) were previously described. 
Imaging of hCPC Translocation in Vivo
Young and old hCPCs were infected with lentiviruses expressing EGFP or RFP, respectively.
The two cell populations were combined in a 1:1 ratio, pre-treated for 10 min with 2 μg/mL of ephrin A1, and mixed with 0.1% volume of InSpek Blue 2.5 µM fluorescent microspheres (Life Technologies). The procedures followed were in accordance with institutional guidelines. Shortly after coronary ligation, 100,000 hCPCs were injected at 4 different sites in the border zone of the hearts of 2-3 month-old C57BL/6 mice. 
Endocytosis of Ephrin A1 and Transferrin
Young and old hCPCs were simultaneously incubated with 1 µg/mL of AlexaFluor-647-conjugated transferrin (Life Technologies) and 1 µg/mL of ephrin A1-FITC to assess the efficiency of ligand internalization into the cytosol. Prior to cell exposure, recombinant ephrin A1-human Fc  was pre-clustered for 5 min with 1.5 µg/mL FITC-conjugated anti-human Fc  (Jackson ImmunoResearch). Following incubation with the two ligands for 5-30 min, hCPCs were subjected to a 2 min acid wash (0.5 M NaCl/0.5 M acetic acid, pH 2.5) to detach the 6 residual ligand bound to the cell surface. 13 Washing of the cells in a buffer solution at pH7.4 allowed the retention of the total bound ligand on the plasma membrane and in the cells.
Fluorescence intensity was determined with a plate reader and normalized to the number of cells, as above, or examined by flow-cytometry. The proportion of the internalized ligand was quantified as % fluorescence intensity after acid wash versus wash at pH 7.4. In a set of experiments, hCPCs were pre-treated with PP2 or H 2 O 2 , as above.
Live imaging of endocytosis dynamics of transferrin and ephrin A1 was studied in young and old hCPCs, which were plated on glass-bottom culture dishes (MatTek). Cells were incubated for 5-45 min with 2 µg/mL of TexasRed-conjugated transferrin (Life Technologies) and pre-clustered ephrin A1-FITC; or ephrin A1-TRITC in hCPCs expressing EGFP. Time-lapse acquisition was performed with Olympus IX71 inverted epifluorescent microscope using CellSens Dimension software (Olympus). Automated recognition and tracking of ephrin A1-TRITC vesicles were performed with Imaris 7.4 software using ImarisTrack module (Bitplane).
Live Imaging of hCPC Migration in Vitro
EGFP-expressing or EphA2-EGFP-infected old hCPCs were plated in a μ-slide I flowchamber (ibidi), subjected to polarized stimulation with HGF, as recommended by manufacturer, and imaged for 7 hr at 37ºC. Time-lapse acquisition was performed as described above and the number of migrating cells, cell velocity and the directionality of movement were analyzed with ImageJ using manual tracking and chemotaxis tool plugin.
Cell Sorting by Adhesion to Ephrin A1
Adhesion assay of hCPCs to immobilized ephrin A1 was performed as previously published. Approximately 10,000 calcein-loaded hCPCs were seeded in each well. Plates were spun down for 2 min and subsequently incubated at 37ºC for 45 minutes. Following extensive washing, the fraction of adhered hCPCs was estimated with fluorescent microplate reader, 488 nm excitation wavelength.
To assess the expression of p16 INK4a and the presence of γH2A.X foci in ephrin A1-adhering and non-adhering hCPCs, the non-adherent cells were collected after the adhesion step. The adherent cells were detached from the plates with a non-enzymatic cell dissociation solution (Sigma). The two populations, as well as unsorted hCPCs incubated with IgG-coated plates, were plated on glass coverslips and analyzed by immunolabeling and confocal microscopy.
Statistical Analysis
Significance between two groups was determined by two-tailed unpaired Student's t test. For multiple comparisons, the ANOVA test with Bonferroni correction was employed. Quantitative data are expressed as mean±SD. Overlay shows the trajectory of individual vesicles generated by automated image segmentation.
Time is indicated (min).
Video 3. Improved motility of old hCPCs after overexpression of functional EphA2. Old hCPCs were infected with lentivirus carrying EphA2-EGFP fusion protein (LV EphA2-EGFP, right) or
